000 | 01814 a2200517 4500 | ||
---|---|---|---|
005 | 20250517194952.0 | ||
264 | 0 | _c20190726 | |
008 | 201907s 0 0 eng d | ||
022 | _a1573-2592 | ||
024 | 7 |
_a10.1007/s10875-018-0477-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDeenick, Elissa K | |
245 | 0 | 0 |
_aReversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency. _h[electronic resource] |
260 |
_bJournal of clinical immunology _c02 2018 |
||
300 |
_a159-162 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCommon Variable Immunodeficiency _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
650 | 0 | 4 | _aImmunophenotyping |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 |
_aLymphocytes _xdrug effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPositron Emission Tomography Computed Tomography |
650 | 0 | 4 |
_aSirolimus _xpharmacology |
650 | 0 | 4 | _aSymptom Assessment |
650 | 0 | 4 |
_aThrombocytopenia _xdiagnosis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMorey, Adrienne | |
700 | 1 | _aDanta, Mark | |
700 | 1 | _aEmmett, Louise | |
700 | 1 | _aFay, Keith | |
700 | 1 | _aGracie, Gary | |
700 | 1 | _aMa, Cindy S | |
700 | 1 | _aMacintosh, Rebecca | |
700 | 1 | _aSmith, Sandy A B C | |
700 | 1 | _aSasson, Sarah C | |
700 | 1 | _aSewell, William A | |
700 | 1 | _aCowley, Mark | |
700 | 1 | _aTangye, Stuart G | |
700 | 1 | _aKelleher, Anthony D | |
700 | 1 | _aPhan, Tri G | |
773 | 0 |
_tJournal of clinical immunology _gvol. 38 _gno. 2 _gp. 159-162 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-018-0477-z _zAvailable from publisher's website |
999 |
_c27995879 _d27995879 |